Shares of Rewalk Robotics Ltd (NASDAQ:RWLK) have received a consensus rating of “Hold” from the seven analysts that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and four have given a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $3.10.
Several equities analysts have recently issued reports on the stock. Jefferies Group cut their price objective on shares of Rewalk Robotics from $8.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 3rd. Oppenheimer set a $3.00 price objective on shares of Rewalk Robotics and gave the company a “buy” rating in a report on Tuesday, December 26th. ValuEngine upgraded shares of Rewalk Robotics from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd. Zacks Investment Research upgraded shares of Rewalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price objective on the stock in a report on Thursday, November 9th. Finally, Canaccord Genuity restated a “buy” rating and set a $3.00 price objective on shares of Rewalk Robotics in a report on Monday, November 6th.
A hedge fund recently raised its stake in Rewalk Robotics stock. Advisor Group Inc. increased its holdings in Rewalk Robotics Ltd (NASDAQ:RWLK) by 73.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 314,650 shares of the medical device company’s stock after buying an additional 132,750 shares during the quarter. Advisor Group Inc. owned about 1.09% of Rewalk Robotics worth $347,000 at the end of the most recent reporting period. 2.02% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: “Rewalk Robotics Ltd (RWLK) Receives Consensus Rating of “Hold” from Brokerages” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.tickerreport.com/banking-finance/3225915/rewalk-robotics-ltd-rwlk-receives-consensus-rating-of-hold-from-brokerages.html.
About Rewalk Robotics
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.